A Paralog-Selective Inhibitor May Allow for Targeting of GSK3{alpha} in AML [Research Watch]

The GSK3α-selective inhibitor BRD0705 promotes AML cell differentiation without increasing β-catenin.

from Cancer via ola Kala on Inoreader http://ift.tt/2FNZbE8
via IFTTT